Article ; Online: Virus-associated ribozymes and nano carriers against COVID-19.
Artificial cells, nanomedicine, and biotechnology
2021 Volume 49, Issue 1, Page(s) 204–218
Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a zoo tonic, highly pathogenic virus. The new type of coronavirus with contagious nature spread from Wuhan (China) to the whole world in a very short time and caused the new coronavirus ... ...
| Abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a zoo tonic, highly pathogenic virus. The new type of coronavirus with contagious nature spread from Wuhan (China) to the whole world in a very short time and caused the new coronavirus disease (COVID-19). COVID-19 has turned into a global public health crisis due to spreading by close person-to-person contact with high transmission capacity. Thus, research about the treatment of the damages caused by the virus or prevention from infection increases everyday. Besides, there is still no approved and definitive, standardized treatment for COVID-19. However, this disaster experienced by human beings has made us realize the significance of having a system ready for use to prevent humanity from viral attacks without wasting time. As is known, nanocarriers can be targeted to the desired cells |
|---|---|
| MeSH term(s) | Angiotensin-Converting Enzyme 2/antagonists & inhibitors ; COVID-19/drug therapy ; Clinical Trials as Topic ; Drug Carriers ; Drug Compounding ; Drug Design ; HIV Infections/drug therapy ; HIV-1/drug effects ; HIV-1/genetics ; Humans ; Middle East Respiratory Syndrome Coronavirus/drug effects ; Middle East Respiratory Syndrome Coronavirus/genetics ; Models, Molecular ; Nanoparticles/administration & dosage ; Nucleic Acid Conformation ; RNA Interference ; RNA, Catalytic/administration & dosage ; RNA, Catalytic/chemistry ; RNA, Catalytic/classification ; RNA, Catalytic/therapeutic use ; RNA, Untranslated/classification ; RNA, Untranslated/genetics ; RNA, Untranslated/therapeutic use ; RNA, Viral/antagonists & inhibitors ; Receptors, Coronavirus/antagonists & inhibitors ; SARS Virus/drug effects ; SARS Virus/genetics ; SARS-CoV-2/drug effects ; SARS-CoV-2/genetics ; SARS-CoV-2/physiology ; Spike Glycoprotein, Coronavirus/physiology ; Virus Replication/drug effects |
| Chemical Substances | Drug Carriers ; RNA, Catalytic ; RNA, Untranslated ; RNA, Viral ; Receptors, Coronavirus ; Spike Glycoprotein, Coronavirus ; hammerhead ribozyme ; spike protein, SARS-CoV-2 ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) |
| Language | English |
| Publishing date | 2021-03-01 |
| Publishing country | England |
| Document type | Journal Article ; Review |
| ZDB-ID | 2723095-8 |
| ISSN | 2169-141X ; 2169-1401 |
| ISSN (online) | 2169-141X |
| ISSN | 2169-1401 |
| DOI | 10.1080/21691401.2021.1890103 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1164: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.